Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

Lizza E. L. \ Hendriks*, Gerben P. Bootsma, Dirk K. M. de Ruysscher, Nicole A. M. Scheppers, Paul A. M. Hofmane, Boudewijn T. Brans, Anne-Marie C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Web of Science)
6 Downloads (Pure)
Original languageEnglish
Pages (from-to)293-297
JournalLung Cancer
Issue number3
Publication statusPublished - Jun 2013


  • Non small cell lung cancer
  • Magnetic resonance imaging
  • Computed tomography
  • Staging
  • (18)FDG-PET
  • Brain metastases

Cite this